Related Experiment Video
Updated: Jul 23, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Absolute quantitation of coronary steal induced by intravenous dipyridamole
O O Akinboboye1, O Idris, R L Chou
1Nuclear Cardiology Laboratory, St. Francis Hospital, Roslyn, New York 11576, USA.
Insights
Intravenous dipyridamole can induce coronary steal, a decrease in blood flow, in nearly half of patients with severe coronary artery disease (CAD). This finding is crucial for understanding myocardial ischemia during vasodilation in CAD patients.
Area of Science:
- Cardiology
- Nuclear Medicine
- Cardiovascular Imaging
Background:
- Myocardial ischemia during vasodilation is often linked to coronary steal.
- Limited data exists on the absolute magnitude of coronary steal in humans.
Purpose of the Study:
- To determine if intravenous (IV) dipyridamole induces coronary steal in patients with severe coronary artery disease (CAD).
- To quantify the absolute decrease in myocardial perfusion during dipyridamole infusion.
Main Methods:
- Eighteen patients with multivessel CAD underwent dynamic positron emission tomography (PET) with 13NH3.
- Myocardial blood flow was assessed at rest and after IV dipyridamole infusion.
- Myocardial blood flow was calculated in absolute terms using a two-compartment model.
Main Results:
- Coronary steal was observed in 8 out of 18 patients (approximately 45%).
- In patients with steal, myocardial blood flow decreased from 90 +/- 18 to 68 +/- 27 ml/100 g/min.
- Segments without steal showed increased blood flow (87 +/- 19 to 138 +/- 16 ml/100 g/min).
- Clinical correlates included ST elevation or ST depression with angina.
Conclusions:
- Intravenous dipyridamole causes significant reductions in blood flow to collateral-dependent myocardium in severe CAD.
- These reductions are consistent with coronary steal in a substantial proportion of patients.
- Findings highlight the importance of assessing absolute myocardial blood flow to detect coronary steal.
Objective:
The study was done to determine whether coronary steal (defined as an absolute decrease in perfusion from resting blood flow) is induced by intravenous (IV) dipyridamole in patients with severe coronary artery disease (CAD).
Background:
Myocardial ischemia during coronary vasodilation is usually attributed to coronary steal. However, there is limited data on the absolute magnitude of coronary steal in humans.
Methods:
Eighteen patients with multivessel CAD underwent dynamic positron emission tomography (PET) imaging with 13NH3 at rest and after infusion of IV dipyridamole. Eight myocardial sectors were analyzed per short axis slice and myocardial blood flow calculated with a two-compartment model in absolute terms.
Results:
Coronary steal occurred in 8 of the 18 patients. In the 8 patients with coronary steal, myocardial blood flow decreased from 90 +/- 18 ml/100 g/min at rest to 68 +/- 27 ml/100 g/min following dipyridamole in the segments with steal, and increased from 87 +/- 19 to 138 +/- 16 ml/100 g/min following dipyridamole in the segments without steal. Significant clinical correlates of coronary steal were either ST elevation or the combination of ST depression and angina.
Conclusions:
Coronary vasodilation with IV dipyridamole is associated with significant reductions in blood flow to collateral-dependent myocardium consistent with coronary steal in about 45% of patients with severe CAD.
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

